The Tat inhibitor didehydro‐cortistatin A suppresses SIV replication and reactivation-Reference-Cited by-同舟云学术

The Tat inhibitor didehydro‐cortistatin A suppresses SIV replication and reactivation

Published:2019-04-25 Issue:7 Volume:33 Page:8280-8293
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Mediouni Sonia¹,Kessing Cari F.¹,Jablonski Joseph A.¹,Thenin-Houssier Suzie²,Clementz Mark¹,Kovach Melia D.¹,Mousseau Guillaume¹,De Vera Ian Mitchelle S.³,Li Chuan¹,Kojetin Douglas J.⁴,Evans David T.⁵,Valente Susana T.¹

Affiliation:

1. Department of Immunology and MicrobiologyThe Scripps Research Institute Jupiter Florida USA

2. Institute of Human Genetics (IGH)CNRSUniversity of Montpelier Montpelier France

3. Department of Pharmacology and PhysiologySt. Louis University School of Medicine St. Louis Missouri USA

4. Department of Molecular TherapeuticsThe Scripps Research Institute Jupiter Florida USA

5. Department of Pathology and Laboratory MedicineUniversity of Wisconsin–Madison Madison Wisconsin USA

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201801165R

Reference55 articles.

1. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

2. Targeting HIV transcription: the quest for a functional cure;Mousseau G.;Curr. Top. Microbiol. Immunol.,2015

3. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product

4. In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions.

5. Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Viral Transcription for HIV Cure Strategies;Microorganisms;2024-04-08

2. New latency-promoting agents for a block-and-lock functional cure strategy;Current Opinion in HIV and AIDS;2024-02-27

3. Eliminating the HIV tissue reservoir: current strategies and challenges;Infectious Diseases;2023-12-27

4. Advances in HIV therapeutics and cure strategies: findings obtained through non-human primate studies;Journal of NeuroVirology;2023-08

5. Loss of In Vivo Replication Fitness of HIV-1 Variants Resistant to the Tat Inhibitor, dCA;Viruses;2023-04-12